Drug Epidemiology and Post-Marketing Surveillance

Hardcover

EditorBrian L. Strom, G.P Velo, Brian L. StrombyBrian L. Strom, Brian L. StromRevised byG.p Velo

not yet rated|write a review
A summary of the material presented in a course examining pharmacoepidemiology, the epidemiological study of adverse reactions to pharmaceutical drugs, which is of increasing interest in the pharmaceutical industry, medical schools, and public health. A major goal of the course was to cross-fertilize the two main approaches, one using formal epidemiological techniques, and the other analyzing spontaneous reporting. Discusses databases, new methodologies, and examples of applications. Annotation c. by Book News, Inc., Portland, Or.

Pricing and Purchase Info

$341.34 online
$375.95 list price (save 9%)
In stock online
Ships free on orders over $25

From the Publisher

A summary of the material presented in a course examining pharmacoepidemiology, the epidemiological study of adverse reactions to pharmaceutical drugs, which is of increasing interest in the pharmaceutical industry, medical schools, and public health. A major goal of the course was to cross-fertilize the two main approaches, one using ...

Format:HardcoverDimensions:180 pages, 9.21 × 6.14 × 0.01 inPublisher:Springer US

The following ISBNs are associated with this title:

ISBN - 10:0306440997

ISBN - 13:9780306440991

Look for similar items by category:

Customer Reviews of Drug Epidemiology and Post-Marketing Surveillance

Reviews

Extra Content

Table of Contents

Spontaneous Reporting: The Analysis of Postmarketing Drug Surveillance Data at the U.S. Food and Drug Administration; T.P. Gross. Pharmacovigilance in France; B. Begaud. Traditional Clinical Epidemiology Methods as Applied to Pharmacoepidemiology: The Use of Cohort Studies in Pharmacoepidemiology; T. Creagh-Kirk. Use of Automated Databases for Pharmacoepidemiology: Screening for Unknown Effects of Newly Marketed Drugs; J.L. Carson, B.L. Strom. Hospital Pharmacoepidemiology: Hospital Data Sources; J.K. Jones. New Methodologic Developments: Approaches to Evaluating Causation of Suspected Drug Reactions; J.K. Jones. Pharmacoeconomics; H. Glick, R. Kington. Selected Examples of Regulatory and Commercial Importance: The Triazolam Experience in 1979 in the Netherlands; R.H.B. Meyboom. Eleven additional articles. Index.